| Literature DB >> 30846706 |
Virginia Lope1,2,3, Miguel Martín3,4,5, Adela Castelló1,2,3, Amparo Ruiz3,6, Ana Mª Casas3,7, José Manuel Baena-Cañada3,8, Silvia Antolín3,9, Manuel Ramos-Vázquez3,10, José Ángel García-Sáenz3,11, Montserrat Muñoz3,12, Ana Lluch3,4,13, Ana de Juan-Ferré3,14, Carlos Jara3,15, Pedro Sánchez-Rovira3,16, Antonio Antón3,17, José Ignacio Chacón3,18, Angels Arcusa3,19, Mª Angeles Jimeno3, Susana Bezares3, Jesús Vioque2,20, Eva Carrasco3, Beatriz Pérez-Gómez1,2,3, Marina Pollán21,22,23.
Abstract
This study analyzes the association of excessive energy intake and caloric restriction with breast cancer (BC) risk taking into account the individual energy needs of Spanish women. We conducted a multicenter matched case-control study where 973 pairs completed lifestyle and food frequency questionnaires. Expected caloric intake was predicted from a linear regression model in controls, including calories consumed as dependent variable, basal metabolic rate as an offset and physical activity as explanatory. Overeating and caloric restriction were defined taking into account the 99% confidence interval of the predicted value. The association with BC risk, overall and by pathologic subtype, was evaluated using conditional and multinomial logistic regression models. While premenopausal women that consumed few calories (>20% below predicted) had lower BC risk (OR = 0.36; 95% CI = 0.21-0.63), postmenopausal women with an excessive intake (≥40% above predicted) showed an increased risk (OR = 2.81; 95% CI = 1.65-4.79). For every 20% increase in relative (observed/predicted) caloric intake the risk of hormone receptor positive (p-trend < 0.001) and HER2+ (p-trend = 0.015) tumours increased 13%, being this figure 7% for triple negative tumours. While high energy intake increases BC risk, caloric restriction could be protective. Moderate caloric restriction, in combination with regular physical activity, could be a good strategy for BC prevention.Entities:
Mesh:
Year: 2019 PMID: 30846706 PMCID: PMC6405854 DOI: 10.1038/s41598-019-39346-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Participant baseline characteristics among breast cancer cases and controls.
| Characteristics | Cases (n = 973) | Controls (n = 973) | p value | ||
|---|---|---|---|---|---|
| Age, mean (±SD) | 50.4 | (±9.6) | 50.2 | (±9.4) | 0.562a |
| Educational level, n(%) | |||||
| No formal education - First grade | 208 | (22) | 160 | (16) | |
| Second grade - Vocational training | 510 | (52) | 491 | (51) | |
| University graduate | 255 | (26) | 322 | (33) | 0.001a |
| Age at menarche, mean(±SD) | 12.6 | (±1.5) | 12.4 | (±1.5) | 0.049b |
| Age at first birth, mean(±SD) | 26.5 | (±4.3) | 26.2 | (±4.3) | 0.097b |
| Number of children, n(%) | |||||
| None | 215 | (22) | 220 | (23) | |
| 1–2 | 593 | (61) | 587 | (60) | |
| 3–4 | 151 | (16) | 149 | (15) | |
| >4 | 14 | (1) | 17 | (2) | 0.942a |
| Menopausal status, n(%) | |||||
| Premenopausal | 551 | (57) | 513 | (53) | |
| Posmenopausal | 422 | (43) | 460 | (47) | 0.084a |
| Body mass index, Kg/m2, mean(±SD) | |||||
| Premenopausal | 24.4 | (±5.9) | 24.7 | (±5.9) | 0.225b |
| Posmenopausal | 27.3 | (±8.1) | 26.2 | (±6.4) | 0.004b |
| Hormone replacement therapy use, n(%) | |||||
| Never | 864 | (89) | 874 | (90) | |
| Ever | 109 | (11) | 99 | (10) | 0.432b |
| Previous benign breast problems, n(%) | |||||
| No | 761 | (78) | 796 | (82) | |
| Yes | 212 | (22) | 177 | (18) | 0.047a |
| Family history of breast cancer, n(%) | |||||
| None | 728 | (75) | 782 | (80) | |
| Second degree | 129 | (13) | 105 | (11) | |
| First degree | 116 | (12) | 86 | (9) | 0.012a |
| Self-assessed physical activity last year, n(%) | |||||
| Sedentary/slightly active | 365 | (37) | 312 | (32) | |
| Moderately active | 339 | (35) | 394 | (41) | |
| Active/very active | 269 | (28) | 267 | (27) | 0.126b |
| Smoking status, n(%) | |||||
| Never smoker | 420 | (43) | 404 | (42) | |
| Former smoker for ≥6 mo. | 258 | (27) | 254 | (26) | |
| Smoker or former smoker for <6 mo. | 295 | (30) | 315 | (32) | 0.287b |
| Caloric intake (Kcal/day), mean(±SD) | 1990.2 | (±615.1) | 1897.2 | (±628.4) | 0.001a |
| Basal metabolic rate (Kcal/day), mean(±SD) | 1316.2 | (±137.6) | 1309.8 | (±122.8) | 0.263b |
| Predicted calories (Kcal/day), mean(±SD) | 1694.5 | (±305.2) | 1718.8 | (±291.1) | 0.072a |
| Mediterranean dietary pattern scorec, n(%) | |||||
| <5.0812 | 254 | (26) | 243 | (25) | |
| 5.0812–6.0047 | 250 | (26) | 243 | (25) | |
| 6.0048–6.8686 | 263 | (27) | 244 | (25) | |
| >6.8686 | 206 | (21) | 243 | (25) | 0.250a |
| Western dietary pattern scorec, n(%) | |||||
| <4.104 | 208 | (22) | 243 | (25) | |
| 4.104–5.150 | 216 | (22) | 243 | (25) | |
| 5.151–6.197 | 254 | (26) | 244 | (25) | |
| >6.197 | 295 | (30) | 243 | (25) | 0.023a |
| Tumour subtyped, n(%) | |||||
| HR+ | 653 | (67) | |||
| HER2+ | 199 | (21) | |||
| TN | 119 | (12) | |||
Abbreviations: SD = standard deviation; HR+= hormone receptor positive tumours (ER+ and/or PR + , with HER2−); HER2+= human epidermal growth factor receptor 2 positive tumours; TN = triple negative tumours.
ap value resulting from Pearson Chi-Square test (variables with no missing values).
bp value resulting from conditional logistic regression models (variables with imputed values).
cAccording to the quartiles in the control group.
dTwo breast cancer cases could not be classified.
Multivariate analysis of caloric intake above or below predicted calories and breast cancer risk by menopausal status.
| All women (n = 1946) | Premenopausal women (n = 1064) | Postmenopausal women (n = 882) | p-het | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| controls | cases | ORa | (95% CI) | p value | controls | cases | ORa | (95% CI) | p value | controls | cases | ORa | (95% CI) | p value | ||
| (n = 973) | (n = 973) | (n = 513) | (n = 551) | (n = 460) | (n = 422) | |||||||||||
| Relative caloric intake | ||||||||||||||||
| More than 20% below predicted calories | 162 | 105 | 0.52 | (0.35–0.78) | 0.001 | 92 | 51 | 0.36 | (0.21–0.63) | <0.001 | 70 | 54 | 0.77 | (0.44–1.35) | 0.365 | 0.001 |
| Up to 20% below predicted calories | 180 | 165 | 0.93 | (0.66–1.31) | 0.685 | 100 | 97 | 0.77 | (0.49–1.24) | 0.283 | 80 | 68 | 1.14 | (0.68–1.92) | 0.624 | 0.503 |
| Within range of predicted calories (ref) | 152 | 136 | 1.00 | 64 | 77 | 1.00 | 88 | 59 | 1.00 | |||||||
| Up to 40% above predicted calories | 301 | 330 | 1.38 | (1.00–1.90) | 0.048 | 156 | 195 | 1.16 | (0.75–1.81) | 0.498 | 145 | 135 | 1.55 | (0.98–2.47) | 0.062 | 0.144 |
| More than 40% above predicted calories | 178 | 237 | 1.92 | (1.31–2.82) | 0.001 | 101 | 131 | 1.40 | (0.85–2.31) | 0.182 | 77 | 106 | 2.81 | (1.65–4.79) | <0.001 | 0.001 |
| |
| < |
|
|
|
|
| |||||||||
Abbreviations: OR = odds ratio; CI = confidence interval; p = p value; p-het = p value for heterogeneity.
aAdjusted for educational level, body mass index one-year before the interview, smoking status, age at menarche, age at first birth (with a category of nulliparous), previous benign breast problems, family history of breast cancer, hormone therapy use, recent physical activity, level of adherence to Mediterranean and Western dietary patterns, and menopausal status (all women). Adjusted for age and hospital by design.
Multivariate logistic analysis of relative caloric intake and breast cancer risk by pathological subtypea.
| controls | HR + (n = 653) | HER2 + (n = 199) | TN (n = 119) | p-het | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (n = 971) | cases | ORb | (95% CI) | p value | cases | ORb | (95% CI) | p value | cases | ORb | (95% CI) | p value | |||
| Relative caloric intake | |||||||||||||||
| More than 20% below predicted calories | 162 | 69 | 0.60 | (0.40–0.91) | 0.015 | 21 | 0.60 | (0.31–1.14) | 0.119 | 15 | 0.55 | (0.25–1.22) | 0.142 | 0.980 | |
| Up to 20% below predicted calories | 180 | 110 | 1.03 | (0.72–1.48) | 0.862 | 38 | 1.27 | (0.73–2.19) | 0.398 | 16 | 0.85 | (0.40–1.78) | 0.658 | 0.631 | |
| Within range of predicted calories (ref) | 152 | 92 | 1.00 | 28 | 1.00 | 16 | 1.00 | ||||||||
| Up to 40% above predicted calories | 299 | 218 | 1.34 | (0.96–1.88) | 0.083 | 65 | 1.44 | (0.86–2.42) | 0.164 | 46 | 1.69 | (0.89–3.22) | 0.109 | 0.782 | |
| More than 40% above predicted calories | 178 | 164 | 1.82 | (1.22–2.70) | 0.003 | 47 | 2.05 | (1.11–3.76) | 0.021 | 26 | 1.89 | (0.88–4.07) | 0.102 | 0.933 | |
| |
| < |
|
|
|
|
| ||||||||
Abbreviations: HR+= hormone receptor positive tumours (ER+ and/or PR+, with HER2-); HER2+= human epidermal growth factor receptor 2 positive tumours; TN = triple negative tumours; OR = odds ratio; CI = confidence interval; p = p value; p-het = p value for heterogeneity.
aTwo breast cancer cases could not be classified.
bAdjusted for age, hospital, educational level, body mass index one-year before the interview, smoking status, age at menarche, age at first birth (with a category of nulliparous), menopausal status, previous benign breast problems, family history of breast cancer, hormone therapy use, recent physical activity, and level of adherence to Mediterranean and Western dietary patterns.
Figure 1Breast cancer risk for every 20% increase in relative calorie consumption according to women characteristics. *Adjusted for menopausal status, educational level, BMI one-year before the interview, smoking status, age at first birth, age at menarche, previous benign breast problems, family history of breast cancer, hormone replacement therapy use, self-assessed physical activity during the last year, Mediterranean dietary pattern and Western dietary pattern.